US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Adways Company Ltd (PK) (ADWYF) 銘柄情報

Adways Company Ltd (PK) (ADWYF)

2.259

0.00

(0.00%)

終了 7月4日 5:00AM

Adways Company Ltd (PK) (ADWYF) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

2.259

( - )

買値

0.01

売値

4,002.35

出来高

-

0.00 日の範囲 0.00

2.259 52 週間の範囲 2.259

時価総額

前日終値

2.259

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 191,836

発行済株式数

39,082,120

配当利回り

6.42

PER

24.58

1 株当たり利益 (EPS)

11.55

歳入

12.36B

純利益

451.56M

Adways Inc. engages in advertisement platform, agency, and other businesses in Japan, China, Korea, Taiwan, the Philippines, Hong Kong, Singapore, and Thailand. It offers AppDriver and UNICORN smartphone advertising services; Smart-C mobile affiliate advertising services; and JANet affiliate adverti... Adways Inc. engages in advertisement platform, agency, and other businesses in Japan, China, Korea, Taiwan, the Philippines, Hong Kong, Singapore, and Thailand. It offers AppDriver and UNICORN smartphone advertising services; Smart-C mobile affiliate advertising services; and JANet affiliate advertising services; and sales and operation services of internet advertising using the group's ad platform. The company is also involved in startup investment, digital transformation business, lifestyle, and overseas businesses; and acts as an agent for the sale of advertising products and related services. Adways Inc. was incorporated in 2001 and is headquartered in Shinjuku, Japan. 詳細を表示

セクター

Technology

業界

Software & It Services

ウェブサイト

www.adways.net

本社

Shinjuku, Japan

設立

2026

Adways Company Ltd (PK) is listed in the Technology sector of the その他OTC with ticker ADWYF. The last closing price for Adways (PK) was US$2.26. Over the last year, Adways (PK) shares have traded in a share price range of US$ 2.259 to US$ 2.259.

Adways (PK) currently has 39,082,120 shares in issue. The market capitalisation of Adways (PK) is US$88.29 million. Adways (PK) has a price to earnings ratio (PE ratio) of 24.58.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	2.259	2.259	2.259	0	0	CS
26	0	0	2.259	2.259	2.259	0	0	CS
52	0	0	2.259	2.259	2.259	0	0	CS
156	0	0	2.259	2.259	2.259	16	2.259	CS
260	0	0	2.259	2.259	2.259	16	2.259	CS

ADWYF - Frequently Asked Questions (FAQ)

What is the current Adways Company Ltd (PK) share price?

The current share price of Adways Company Ltd (PK) is US$ 2.259

How many Adways Company Ltd (PK) shares are in issue?

Adways Company Ltd (PK) has 39,082,120 shares in issue

What is the market cap of Adways Company Ltd (PK)?

The market capitalisation of Adways Company Ltd (PK) is USD 88.29M

What is the 1 year trading range for Adways Company Ltd (PK) share price?

Adways Company Ltd (PK) has traded in the range of US$ 2.259 to US$ 2.259 during the past year

What is the PE ratio of Adways Company Ltd (PK)?

The price to earnings ratio of Adways Company Ltd (PK) is 24.58

What is the cash to sales ratio of Adways Company Ltd (PK)?

The cash to sales ratio of Adways Company Ltd (PK) is 0.9

What is the registered address of Adways Company Ltd (PK)?

The registered address for Adways Company Ltd (PK) is Sumitomo Fudousan Shinjuku FirstTower, Shinjuku, Tokyo, 160-0023

What is the Adways Company Ltd (PK) website address?

The website address for Adways Company Ltd (PK) is www.adways.net

Which industry sector does Adways Company Ltd (PK) operate in?

Adways Company Ltd (PK) operates in the Software & IT Services sector

scotty3371

scotty3371 3分前

There is nothing in the official BNOS Constitution or foundational bylaws that dictates a mandatory online post-presentation waiting period or abstract embargo for presenting companies.
GOOD JOB I/R.

northofadollar

northofadollar 3分前

I was hoping the webinar would have indicated they were digging the first treasure target. Really sad operationally. They are convinced the tech is accurate but can't get to the targets. I know the environment at Juno is difficult but at some point they have to perform.

chereb19

chereb19 3分前

"A dead tumor is a dead tumor" has to be one of the most scientifically illiterate statements in this entire discussion. By that logic every cancer therapy is identical because the goal is the same. That's basic science thrown out of the window.

You keep reducing oncology to a slogan

norisknorewards

norisknorewards 4分前

Ken griffen will find a way to act like it never happened, unfortunately.

GTF

But you should also know that at the end of the 12 month restriction you have to pay close to a thousand dollars to have the shares released to be tradeable. You will have to get an attorney's opinion to give to your broker, get Legacy to verify it and release them. They will charge you for this. Yo

europa7

europa7 5分前

Companies Using Ripple for Cross-Border Payments: The Full 2026 Picture
17 June 2026
https://memeburn.com/companies-using-ripple-for-cross-border-payments/

"...Ripple's cross-border payment network now includes over 300 financial institutions, with major 2026 additions l

Idunno

DC-VAX was just derisked to/for BP. IMO. Combo platforms. Can’t ignore NWBO any longer. 🤷🏻‍♂️

Patswil

Patswil 7分前

For anybody who can't remember, $40 billion was taken from Fannie and Fred to bail out the solving banks. Then Hank Paulson did even more damage

zzNine2Five

zzNine2Five 7分前

Does anyone know if BA is invited to DC for the 250 years ceremony which could imply if he is one of the inner circle. Being with F2 for over 19 years, from my limited observation, he hasn’t yet brought any good luck to the stocks instead of pumping and dumping saga.
Fnma was $9.48 on July 3

surfer44

surfer44 7分前

Warren Buffett Breaks His Silence on the U.S. Stock Market

https://youtu.be/oIBwNHgJj08

j e d

This is the biggest thing since the Advent acquisition, if not bigger.

JAB65

Never thought about that. That would certainly save them a few hundred million. Is there enough capacity, compression or whatever the criteria is to piggyback on Williams? Would they prefer to have their own control with a new station?

That would be just like Delfin to pivot after bat

fredscott36

fredscott36 9分前

..dude......will get 'em both, and the G-wagon is ordered, and the 4-runner......not firm on the wrangler, but definitely a wrangler............gotta fill up the garages with a new fleet.........boys toys................($40mios in the tip jar??)...............

.....the POS.....???.

US Market News

US Market News 10分前

Robert Half receives three Canadian HR Reporter Readers' Choice Awards 2026, for 11th consecutive yearJuly 3, 2026 12:38 PM
PR Newswire (Canada) class="legendSpanClass"TORONTO, class="legendSpanClass"July 3, 2026 /CNW/ - Global talent so

KeepItRealistic

KeepItRealistic 10分前

$OSRH to new long investors buy 10k shares and HOLD and while turning your 10k shares to 60k shares 👇

• Details: One non-transferable CVR per share held as of the record date (targeted for July 31, 2026). Subject to legal counsel approval.

• Tiered Rewards: T

williamssc

williamssc 13分前

Slide16 “Overall Conclusions: The survival benefit associated with DCVax-L treatment reflects a true treatment affect and was underestimated in the original analysis”

https://nwbio.com/wp-content/uploads/NWBT-BNOS-slides-7-3-26MB-LP-final.pdf

NASDAQ2020

NASDAQ2020 14分前

i will wait for Monday to grab some more ??

GoodGuyBill

GoodGuyBill 15分前

Brazen22, you’re trying to reduce three years of regulatory progress to one sentence: “You don’t have an approved MAA.”

Of course we don’t — yet. Approval is the destination. We have a validated MAA. What matters is whether NWBO has completed the steps that regulators require before a

NASDAQ2020

NASDAQ2020 15分前

THATS WHEN i ACCUMULATE. At The hammerbottom.

nowwhat2

nowwhat2 15分前

Nonbelievers . . . . . C L E A R THE R U N W A Y
$3.50 CDN is pretty strong support.

https://investorshub.advfn.com/uimage/uploads/2026/7/3/vwgethg_july_3_2y_plunge_sell.jpg

rizona

rizona 17分前

Slides! JAMA study UNDERESTIMATED survival benefit

https://nwbio.com/wp-content/uploads/NWBT-BNOS-slides-7-3-26MB-LP-final.pdf

rosemountbomber

rosemountbomber 18分前

I agree with your thinking and also what needs to be considered is after decimating the board, just a desire to be acquired doesn’t automatically make that happen. Some other party has to be interested in acquiring Amarin. What happens then if no one steps up?

chereb19

chereb19 18分前

This is another post built on false equivalence. Sharing Y-90 doesn't make two products the same any more than sharing aspirin makes every painkiller identical.

You keep calling them competitors while ignoring they're fundamentally different technologies. One is a hydrogel platform, t

NASDAQ2020

NASDAQ2020 20分前

Im glad I held my shares past $0.15

Phio Pharmaceuticals

Magnetite Mines

ArrowMark Financial

Alpha Peak Leisure

Amprius Technologies

Australia and New Zealan...

Investigator Resources

Estrella Resources

Glennon Small Companies

Klotho Neurosciences

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。